Drug-induced Parkinson's syndrome is a dubious disease in the field of the nervous system, clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment plans. Treatment plans for drug-induced Parkinson's syndrome require individual characteristics, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of drug-induced Parkinson's syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.